Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism

Clinical and Experimental Nephrology

Volumn 9, Issue 2, 2005, Pages 142-147

  Oyama, Yuko ^a   Kazama, Junichiro James ^a   Omori, Kentaro ^a   Higuchi, Noboru ^a   Kameda, Shigemi ^a   Yamamoto, Suguru ^a   Ito, Yumi ^a   Maruyama, Hiroki ^a   Narita, Ichiei ^a   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Intact parathyroid hormone; Maxacalcitol; Phosphate; Secondary hyperparathyroidism

Indexed keywords

22 OXACALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARATHYROID FUNCTION; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SECONDARY HYPERPARATHYROIDISM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CALCITRIOL; CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 21044459358     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-005-0342-2     Document Type: Article

References (28)

1. TB Drueke 2002 Treatment of secondary hyperparathyroidism with vitamin D derivatives and calcimimetics before and after start of dialysis Nephrol Dial Transplant 17 s11 20 2
2. N Fukuda H Tanaka Y Tominaga M Fukagawa K Kurokawa Y Seino 1993 Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients J Clin Invest 92 1436 43
3. Y Tominaga S Kohara Y Namii T Nagasaka T Haba K Uchida 1996 Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism World J Surg 20 744 50
4. M Tokumoto K Tsuruya K Fukuda H Kanai S Kuroki H Hirakata 2002 Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism Kidney Int 62 1196 207
5. CH Hsu 1997 Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 29 641 9
6. SMDr Moe 2003 ueke TB. Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product Am J Nephrol 23 369 79
7. M Fukagawa M Kitaoka H Yi N Fukuda T Matsumoto E Ogata 1994 Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients Nephron 68 221 8
8. N Onoda S Kurihara Y Sakurai K Owada E Osono H Adachi 2003 Evaluation of blood supply to the parathyroid glands in secondary hyperparathyroidism compared with histopathology Nephrol Dial Transplant 18 s3 34 7
9. Brown AJ, Ritter CR, Finch JL, Morrissey J, Martin KJ, Murayama E, et al. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J Clin Invest 1989;84:728-32.
10. Y Nishii T Okano 2001 History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2beta-(3-hydroxypropoxy) calcitriol (ED-71 Steroids 66 137 46
11. K/DOQI Clinical practice guidelines for bone mineral metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(Suppl 3):S7-S201
12. JA Hanley 1989 Receiver operating characteristic (ROC) methodology: the state of the art Crit Rev Diagn Imaging 29 307 35
13. JJ Kazama K Kutsuwada K Ataka H Maruyama F Gejyo 2002 Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases Nephron 91 13 20
14. M Rodriguez AJ Felsenfeld C Williams JA Pederson F Llach 1991 The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients J Am Soc Nephrol 2 1014 20
15. F Malberti B Corradi P Cosci F Calliada D Marcelli E Imbasciati 1996 Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism Am J Kidney Dis 28 704 12
16. M Yasuda T Akiba H Nihei 2003 Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients Am J Kidney Dis 41 s1 S108 11
17. JJ Kazama F Sato K Omori H Hama S Yamamoto H Maruyama 2005 Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients Kidney Int 67 1120 5
18. M Fukagawa Y Tominaga M Kitaoka T Kakuta K Kurokawa 1999 Medical and surgical aspects of parathyroidectomy Kidney Int 73 s1 S65 9
19. CS Ritter JL Finch EA Slatopolsky AJ Brown 2001 Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor Kidney Int 60 1737 44
20. M Rodriguez A Canalejo B Garfia E Aguilera Y Almaden 2002 Pathogenesis of refractory secondary hyperparathyroidism Kidney Int 80 s1 S155 60
21. E Slatopolsky A Brown A Dusso 2001 Role of phosphorus in the pathogenesis of secondary hyperparathyroidism Am J Kidney Dis 37 s1 S54 7
22. A Jara C Chacon AJ Felsenfeld 2002 Hyperphosphatemia modestly retards parathyroid hormone suppression during calcitriol-induced hypercalcemia in normal and azotemic rats Nephron 92 883 8
23. T Akizawa M Suzuki T Akiba Y Nishizawa Y Ohashi E Ogata 2002 Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study Nephrol Dial Transplant 17 s10 28 36
24. Y Tsukamoto M Hanaoka T Matsuo T Saruta M Nomura Y Takahashi 2000 Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism Am J Kidney Dis 35 458 64
25. JJ Kazama K Omori N Higuchi N Takahashi Y Ito H Maruyama 2004 Intact PTH assay overestimates 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism Nephrol Dial Transplant 19 892 7
26. S Doi N Yorioka K Usui K Shigemoto S Harada 2003 Effect of 22-oxacalcitriol on secondary hyperparathyroidism in hemodialysis patients Intern Med 42 955 9
27. 3 and 22-oxacalcitriol on phosphate and calcium metabolism Kidney Int 43 561 6
28. 3 Nephrol Dial Transplant 18 1770 6